Tibsovo
(ivosidenib)TIBSOVO 250 MG Oral Tablet
Dosage & administration
500 mg orally once daily with or without food until disease progression or unacceptable toxicity . Avoid a high-fat meal.
Most viewed Tibsovo resources
biomarker testing
Tibsovo clinical details
Genetic testing requirements were obtained from the NCCN guidelines for each cancer type. drug label
Tibsovo prescribing information
prior authorization
Tibsovo prior authorization resources
Benefits investigation
Learn MoreBenefits investigations are conducted to determine whether a therapy is covered under a patient's insurance, if a prior authorization is required, and which specialty pharmacies are preferred.
pharmacy
Tibsovo preferred pharmacy
financial assistance
Tibsovo financial assistance options
Co-pay savings program
Learn MoreOverview
- Reduce patient OOP costs for drug (and occasionally for drug administration/infusion costs or drug-related test costs)
Patient benefit
- A portion (or all) of patient OOP (deductible, copay), typically up to monthly and/or annual max
Patient eligibility
- Patient must enroll or activate (may permit HCPs to enroll on patient’s behalf for HCP-administered drugs)
- Generally, must have commercial insurance (rarely, may permit uninsured patients to use)
- May never be used with government insurance
How to sign up
- Cards may be downloadable digital cards or hard copies
- Some pharmacos offer debit cards with pre-loaded copay benefit
- Typically, available through multiple channels (e.g., rep to HCP to patient; pharmacy to patient; patient via website, Hub live agent, or copay vendor (live agent or IVR); patient and HCP via Hub enrollment form)
- Some HCP-administered product programs permit HCPs to enroll on a patient’s behalf through via Hub form
Bridge program
Learn MoreOverview
- Provide patient immediate access to therapy during an insurance delay (typically new starts; some may cover change in insurance)
- Limited time/ fill (typically 7-30 days; some may offer additional fill for continued delay up to certain limit)
Patient benefit
- 100% free (outside of insurance)
Patient eligibility
- HCP must enroll patient
- May be limited to commercially insured patients (i.e., no government beneficiaries); some programs may allow government beneficiaries
How to sign up
- Typically HCP assisted enrollment (via form)
Foundation programs
Learn MoreOverview
- Charitable 501(c)(3) organizations provide direct cost-sharing and other support (e.g., travel, counseling) through disease-state funds to indigent patients on first-come first-served basis
- These organizations may receive financial contributions from drug manaufacturers for particular disease-state funds that cannot provide funds directly to patients - the foundation must be independent/unaligned
Patient benefit
- Patients apply for grants that cover a portion (or all) of their out-of-pocket costs (deductibles and co-pays) until the grant is exhausted
Patient eligibility
- Patients must apply and meet eligibility criteria including income level (typically a multiple of federal poverty line), specific diagnosis, insurance status, etc.
How to sign up
- Patients submit proof of out-of-pocket drug costs to charities for reimbursement
patient education
Tibsovo patient education
Getting started on Tibsovo
To share resource; ask patient to: 1.Pull out phone
2.Open camera
3.Scan QR code with camera
Other resources
Learn MoreOther resources brands publish to help support patients.
people also ask
Tibsovo FAQs
How is the dosage of Tibsovo?Tibsovo is available in 1 dosages, including 250 mg Tab
What does Tibsovo treat?Tibsovo treats Acute Myeloid Leukemia
How Is Tibsovo Administered?Tibsovo is administered as a Oral Pill
We receive information directly from the FDA and PrescriberPoint is updated as frequently as change are made available
